Table 3.
Associations of Lp(a) levels with CAC progression*
CAC progression | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1–100 U/year | >100 U/year | |||||||||
Events/# at risk | Model 1† RR (95% CI) | p-value | Model 2‡ RR (95% CI) | p-value | Events/# at risk | Model 1 RR (95% CI) | p-value | Model 2 RR (95% CI) | p-value | |
Lp(a) level | ||||||||||
<30 mg/dL | 2289/4017 | 1.00 | 1.00 | 255/4017 | 1.00 | 1.00 | ||||
≥30 mg/dL | 1069/1958 | 1.07 (0.93, 1.23) | 0.34 | 1.00 (0.86, 1.16) | 0.97 | 146/1958 | 1.50 (1.16, 1.92) | 0.002 | 1.48 (1.12, 1.95) | 0.005 |
<50 mg/dL | 2716/4794 | 1.00 | 1.00 | 297/4794 | 1.00 | 1.00 | ||||
≥50 mg/dL | 642/1181 | 1.05 (0.92, 1.19) | 0.49 | 1.00 (0.87, 1.15) | 0.98 | 104/1181 | 1.81 (1.38, 2.39) | <0.001 | 1.67 (1.23, 2.27) | 0.001 |
CAC=coronary artery calcification, RR=relative risk
Results of multivariable relative risk regression models
Model 1 adjusted for age, sex, race, education, and clinic site
Model 2 adjusted for Model 1 + cigarette smoking, body mass index, diabetes, hypertension, family history of coronary heart disease, total cholesterol, HDL cholesterol, eGFR, hs-CRP, statin use, and aspirin use